Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
55.16 -0.14  -0.25% NYSE Apr 23, 4:59PM BATS Real time Currency in USD

GlaxoSmithKline Cash from Financing (TTM):

-10.34B for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

GlaxoSmithKline Cash from Financing (TTM) Chart

Export Data
Save Image

GlaxoSmithKline Historical Cash from Financing (TTM) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 -10.34B
Sept. 30, 2013 -9.056B
June 30, 2013 -9.059B
March 31, 2013 -5.623B
Dec. 31, 2012 -5.400B
Sept. 30, 2012 -5.724B
June 30, 2012 -6.438B
March 31, 2012 -9.497B
Dec. 31, 2011 -9.607B
Sept. 30, 2011 -9.139B
June 30, 2011 -8.041B
March 31, 2011 -8.298B
Dec. 31, 2010 -8.636B
Sept. 30, 2010 -9.292B
June 30, 2010 -5.359B
March 31, 2010 -5.965B
Dec. 31, 2009 -4.459B
Sept. 30, 2009 -3.365B
June 30, 2009 -8.886B
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Financing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More

Get data for
Advertisement

GSK Cash from Financing (TTM) Benchmarks

Companies
AstraZeneca -3.047B
Johnson & Johnson -6.091B
Eli Lilly and -3.829B

GSK Cash from Financing (TTM) Range, Past 5 Years

Minimum -10.34B Dec 2013
Maximum -3.365B Sep 2009
Average -7.483B
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.